RxDoctor Payments Data

Patrick Daley

Pediatrics · Tulsa, OKNPI 1932183548

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (40.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Supernus Pharmaceuticals, Inc. accounts for 75.8% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $4,018 and has fallen 99.6% since, to $15 in 2025. Among pediatrics clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,884in general payments, 2019–2025

Across 75 payments — averaging $65.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$4K
  • Tris Pharma Inc$228
  • Takeda Pharmaceuticals U.S.A., Inc.$178
  • GSK$150
  • Ironshore Pharmaceuticals Inc.$139
  • Corium, LLC$99
  • plus $387 from 13 others

What the payments were for

  • Speaking & faculty fees$2,00041%
  • Travel & lodging$1,31827%
  • Food & beverage$1,56632%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,884 in reported general payments places this provider in the 95th percentile of 568 pediatrics providers in Oklahoma.

See all pediatrics providers in Oklahoma

Other pediatrics in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →